Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

109 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Treating hyperlipidemia for the primary prevention of coronary disease. Are higher dosages of lovastatin cost-effective?
Perreault S, Hamilton VH, Lavoie F, Grover S. Perreault S, et al. Among authors: lavoie f. Arch Intern Med. 1998 Feb 23;158(4):375-81. doi: 10.1001/archinte.158.4.375. Arch Intern Med. 1998. PMID: 9487235
The importance of indirect costs in primary cardiovascular disease prevention: can we save lives and money with statins?
Grover SA, Ho V, Lavoie F, Coupal L, Zowall H, Pilote L. Grover SA, et al. Among authors: lavoie f. Arch Intern Med. 2003 Feb 10;163(3):333-9. doi: 10.1001/archinte.163.3.333. Arch Intern Med. 2003. PMID: 12578514
Cost-effectiveness of lipid-lowering treatment according to lipid level.
Pilote L, Ho V, Lavoie F, Coupal L, Zowall H, Grover SA. Pilote L, et al. Among authors: lavoie f. Can J Cardiol. 2005 Jun;21(8):681-7. Can J Cardiol. 2005. PMID: 16003451
A head-to-head comparison of the cost effectiveness of HMG-CoA reductase inhibitors and fibrates in different types of primary hyperlipidemia.
Perreault S, Hamilton VH, Lavoie F, Grover S. Perreault S, et al. Among authors: lavoie f. Cardiovasc Drugs Ther. 1997 Jan;10(6):787-94. doi: 10.1007/BF00053037. Cardiovasc Drugs Ther. 1997. PMID: 9110123 Clinical Trial.
Cardiac procedure use and outcomes in elderly patients with acute myocardial infarction in the United States and Quebec, Canada, 1988 to 1994.
Pilote L, Saynina O, Lavoie F, McClellan M. Pilote L, et al. Among authors: lavoie f. Med Care. 2003 Jul;41(7):813-22. doi: 10.1097/00005650-200307000-00005. Med Care. 2003. PMID: 12835605
Drug utilization review of celecoxib in Ontario.
LeLorier J, Fitzsimon C, Keresteci M, Stewart D, Lavoie F. LeLorier J, et al. Among authors: lavoie f. Rheumatology (Oxford). 2003 Nov;42 Suppl 3:iii11-6. doi: 10.1093/rheumatology/keg493. Rheumatology (Oxford). 2003. PMID: 14585913
Effectiveness and cost-effectiveness of antibiotic treatments for community acquired pneumonia (CAP) and acute exacerbations of chronic bronchitis (AECB).
Lavoie F, Blais L, Castilloux AM, Scalera A, LeLorier J. Lavoie F, et al. Can J Clin Pharmacol. 2005 Summer;12(2):e212-7. Epub 2005 Jun 23. Can J Clin Pharmacol. 2005. PMID: 15998960
Changes in the treatment and outcomes of acute myocardial infarction in Quebec, 1988-1995.
Pilote L, Lavoie F, Ho V, Eisenberg MJ. Pilote L, et al. Among authors: lavoie f. CMAJ. 2000 Jul 11;163(1):31-6. CMAJ. 2000. PMID: 10920727 Free PMC article.
Persistency of use of COX-2-specific inhibitors and non-specific non-steroidal anti-inflammatory drugs (NSAIDs) in Quebec.
Moride Y, Ducruet T, Rochon S, Lavoie F. Moride Y, et al. Among authors: lavoie f. Rheumatology (Oxford). 2003 Nov;42 Suppl 3:iii17-22. doi: 10.1093/rheumatology/keg494. Rheumatology (Oxford). 2003. PMID: 14585914
Utilization of non-steroidal anti-inflammatory drugs in Quebec: adherence to the Canadian consensus on prescription guidelines.
Moride Y, Ducruet T, Boivin JF, Lavoie F, Rochon S. Moride Y, et al. Among authors: lavoie f. Can J Clin Pharmacol. 2005 Summer;12(2):e201-11. Epub 2005 Jun 17. Can J Clin Pharmacol. 2005. PMID: 15998959
109 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback